{"id":"https://openalex.org/W2077083000","doi":"https://doi.org/10.7326/m13-2942","title":"Comparative Effectiveness of Generic and Brand-Name Statins on Patient Outcomes","display_name":"Comparative Effectiveness of Generic and Brand-Name Statins on Patient Outcomes","publication_year":2014,"publication_date":"2014-09-15","ids":{"openalex":"https://openalex.org/W2077083000","doi":"https://doi.org/10.7326/m13-2942","mag":"2077083000","pmid":"https://pubmed.ncbi.nlm.nih.gov/25222387"},"language":"en","primary_location":{"id":"doi:10.7326/m13-2942","doi":"https://doi.org/10.7326/m13-2942","is_oa":false,"landing_page_url":"https://doi.org/10.7326/m13-2942","pdf_url":null,"source":{"id":"https://openalex.org/S119722071","display_name":"Annals of Internal Medicine","issn_l":"0003-4819","issn":["0003-4819","1539-3704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316812","host_organization_name":"American College of Physicians","host_organization_lineage":["https://openalex.org/P4310316812"],"host_organization_lineage_names":["American College of Physicians"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Internal Medicine","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:33177339","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5059157113","display_name":"Joshua J. Gagne","orcid":"https://orcid.org/0000-0001-5428-9733","observed_orcids":["https://orcid.org/0000-0001-5428-9733"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210115892","display_name":"CVS Health (United States)","ror":"https://ror.org/02jfw4p72","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joshua J. Gagne","raw_affiliation_strings":["From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210115892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091282674","display_name":"Niteesh K. Choudhry","orcid":"https://orcid.org/0000-0001-7719-2248","observed_orcids":["https://orcid.org/0000-0001-7719-2248"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210115892","display_name":"CVS Health (United States)","ror":"https://ror.org/02jfw4p72","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Niteesh K. Choudhry","raw_affiliation_strings":["From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210115892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074257304","display_name":"Aaron Seth Kesselheim","orcid":"https://orcid.org/0000-0002-8867-2666","observed_orcids":["https://orcid.org/0000-0002-8867-2666"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210115892","display_name":"CVS Health (United States)","ror":"https://ror.org/02jfw4p72","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron S. Kesselheim","raw_affiliation_strings":["From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210115892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103224112","display_name":"Jennifer M. Polinski","orcid":"https://orcid.org/0000-0002-4571-1434","observed_orcids":["https://orcid.org/0000-0002-4571-1434"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210115892","display_name":"CVS Health (United States)","ror":"https://ror.org/02jfw4p72","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jennifer M. Polinski","raw_affiliation_strings":["From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210115892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075994057","display_name":"David S. Hutchins","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210115892","display_name":"CVS Health (United States)","ror":"https://ror.org/02jfw4p72","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Hutchins","raw_affiliation_strings":["From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210115892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029672532","display_name":"Olga S. Matlin","orcid":"https://orcid.org/0009-0004-1914-7595","observed_orcids":["https://orcid.org/0009-0004-1914-7595"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210115892","display_name":"CVS Health (United States)","ror":"https://ror.org/02jfw4p72","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Olga S. Matlin","raw_affiliation_strings":["From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210115892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103949633","display_name":"Troyen A. Brennan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210115892","display_name":"CVS Health (United States)","ror":"https://ror.org/02jfw4p72","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Troyen A. Brennan","raw_affiliation_strings":["From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210115892"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036726043","display_name":"Jerry Avorn","orcid":"https://orcid.org/0000-0003-0255-2346","observed_orcids":["https://orcid.org/0000-0003-0255-2346"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210115892","display_name":"CVS Health (United States)","ror":"https://ror.org/02jfw4p72","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jerry Avorn","raw_affiliation_strings":["From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210115892"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060167116","display_name":"William H. Shrank","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]},{"id":"https://openalex.org/I4210115892","display_name":"CVS Health (United States)","ror":"https://ror.org/02jfw4p72","country_code":"US","type":"company","lineage":["https://openalex.org/I4210115892"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"William H. Shrank","raw_affiliation_strings":["From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"From the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, and CVS Caremark, Woonsocket, Rhode Island","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984","https://openalex.org/I4210115892"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":21.7822,"has_fulltext":false,"cited_by_count":155,"citation_normalized_percentile":{"value":0.99706863,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"161","issue":"6","first_page":"400","last_page":"407"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.5088000297546387,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.5088000297546387,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11620","display_name":"Medication Adherence and Compliance","score":0.47850000858306885,"subfield":{"id":"https://openalex.org/subfields/2714","display_name":"Family Practice"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.004699999932199717,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/generic-drugs","display_name":"generic drugs","score":0.7910000085830688},{"id":"https://openalex.org/keywords/brand-name-drugs","display_name":"brand-name drugs","score":0.9800000190734863},{"id":"https://openalex.org/keywords/statins","display_name":"statins","score":0.9980000257492065},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.8190000057220459},{"id":"https://openalex.org/keywords/proportion-of-days-covered","display_name":"proportion of days covered","score":0.8320000171661377},{"id":"https://openalex.org/keywords/lovastatin","display_name":"lovastatin","score":0.7429999709129333},{"id":"https://openalex.org/keywords/pravastatin","display_name":"pravastatin","score":0.9990000128746033},{"id":"https://openalex.org/keywords/simvastatin","display_name":"simvastatin","score":1.0},{"id":"https://openalex.org/keywords/acute-coronary-syndrome","display_name":"acute coronary syndrome","score":0.8450000286102295},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.8679999709129333},{"id":"https://openalex.org/keywords/all-cause-mortality","display_name":"all-cause mortality","score":0.984000027179718},{"id":"https://openalex.org/keywords/medicare-beneficiaries","display_name":"Medicare beneficiaries","score":0.8429999947547913},{"id":"https://openalex.org/keywords/older-adults","display_name":"older adults","score":0.796999990940094},{"id":"https://openalex.org/keywords/cardiovascular-disease-prevention","display_name":"cardiovascular disease prevention","score":0.6330000162124634}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9558238983154297},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.7312593460083008},{"id":"https://openalex.org/C2779519902","wikidata":"https://www.wikidata.org/wiki/Q1240093","display_name":"Pravastatin","level":3,"score":0.6689201593399048},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6685170531272888},{"id":"https://openalex.org/C2426938","wikidata":"https://www.wikidata.org/wiki/Q3355478","display_name":"Medical prescription","level":2,"score":0.5690513253211975},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5547649264335632},{"id":"https://openalex.org/C2777698277","wikidata":"https://www.wikidata.org/wiki/Q266018","display_name":"Acute coronary syndrome","level":3,"score":0.5197441577911377},{"id":"https://openalex.org/C17923572","wikidata":"https://www.wikidata.org/wiki/Q7250160","display_name":"Propensity score matching","level":2,"score":0.5074798464775085},{"id":"https://openalex.org/C23131810","wikidata":"https://www.wikidata.org/wiki/Q818574","display_name":"Observational study","level":2,"score":0.5051479935646057},{"id":"https://openalex.org/C72563966","wikidata":"https://www.wikidata.org/wiki/Q1303415","display_name":"Cohort","level":2,"score":0.478349894285202},{"id":"https://openalex.org/C2778858636","wikidata":"https://www.wikidata.org/wiki/Q1643563","display_name":"Prescription drug","level":3,"score":0.4691822826862335},{"id":"https://openalex.org/C201903717","wikidata":"https://www.wikidata.org/wiki/Q1778788","display_name":"Cohort study","level":2,"score":0.41800999641418457},{"id":"https://openalex.org/C500558357","wikidata":"https://www.wikidata.org/wiki/Q12152","display_name":"Myocardial infarction","level":2,"score":0.27111825346946716},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.1683676540851593},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.12339726090431213},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.10193198919296265}],"mesh":[{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006278","descriptor_name":"Medicare","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011306","descriptor_name":"Prescription Fees","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015331","descriptor_name":"Cohort Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016568","descriptor_name":"Drugs, Generic","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":true},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000191","qualifier_name":"economics","is_major_topic":false},{"descriptor_ui":"D019161","descriptor_name":"Hydroxymethylglutaryl-CoA Reductase Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055118","descriptor_name":"Medication Adherence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D057216","descriptor_name":"Propensity Score","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.7326/m13-2942","doi":"https://doi.org/10.7326/m13-2942","is_oa":false,"landing_page_url":"https://doi.org/10.7326/m13-2942","pdf_url":null,"source":{"id":"https://openalex.org/S119722071","display_name":"Annals of Internal Medicine","issn_l":"0003-4819","issn":["0003-4819","1539-3704"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316812","host_organization_name":"American College of Physicians","host_organization_lineage":["https://openalex.org/P4310316812"],"host_organization_lineage_names":["American College of Physicians"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of Internal Medicine","raw_type":"journal-article"},{"id":"pmid:25222387","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25222387","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Annals of internal medicine","raw_type":"Comparative Study"},{"id":"pmh:oai:dash.harvard.edu:1/33177339","doi":null,"is_oa":true,"landing_page_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:33177339","pdf_url":null,"source":{"id":"https://openalex.org/S4306401540","display_name":"Digital Access to Scholarship at Harvard (DASH) (Harvard University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I136199984","host_organization_name":"Harvard University","host_organization_lineage":["https://openalex.org/I136199984"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"}],"best_oa_location":{"id":"pmh:oai:dash.harvard.edu:1/33177339","doi":null,"is_oa":true,"landing_page_url":"http://nrs.harvard.edu/urn-3:HUL.InstRepos:33177339","pdf_url":null,"source":{"id":"https://openalex.org/S4306401540","display_name":"Digital Access to Scholarship at Harvard (DASH) (Harvard University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I136199984","host_organization_name":"Harvard University","host_organization_lineage":["https://openalex.org/I136199984"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Journal Article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[{"id":"https://openalex.org/G2632410539","display_name":null,"funder_award_id":"2010A057139","funder_id":"https://openalex.org/F4320308970","funder_display_name":"Teva Pharmaceutical Industries"}],"funders":[{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":42,"referenced_works":["https://openalex.org/W7817381","https://openalex.org/W38523360","https://openalex.org/W1852706946","https://openalex.org/W1965739075","https://openalex.org/W1972113220","https://openalex.org/W1973420370","https://openalex.org/W1981515914","https://openalex.org/W1984959392","https://openalex.org/W1989247444","https://openalex.org/W2009428399","https://openalex.org/W2019683754","https://openalex.org/W2021042232","https://openalex.org/W2034718681","https://openalex.org/W2036483116","https://openalex.org/W2043263931","https://openalex.org/W2052049585","https://openalex.org/W2058647728","https://openalex.org/W2061344582","https://openalex.org/W2067032911","https://openalex.org/W2072073513","https://openalex.org/W2076859422","https://openalex.org/W2078864553","https://openalex.org/W2082929679","https://openalex.org/W2087018232","https://openalex.org/W2100232288","https://openalex.org/W2104761168","https://openalex.org/W2109870370","https://openalex.org/W2110171695","https://openalex.org/W2118184073","https://openalex.org/W2122833169","https://openalex.org/W2127674385","https://openalex.org/W2135792351","https://openalex.org/W2144113585","https://openalex.org/W2150291618","https://openalex.org/W2157724767","https://openalex.org/W2161442856","https://openalex.org/W2163212095","https://openalex.org/W2318669059","https://openalex.org/W2322095705","https://openalex.org/W2323097975","https://openalex.org/W2415649908","https://openalex.org/W4233216783"],"related_works":["https://openalex.org/W7096407111","https://openalex.org/W3114756237","https://openalex.org/W4240635307","https://openalex.org/W1999888718","https://openalex.org/W2277058807","https://openalex.org/W7098919689","https://openalex.org/W2109622927","https://openalex.org/W2902592518","https://openalex.org/W6977161573","https://openalex.org/W2905873723"],"abstract_inverted_index":{"BACKGROUND:":[0],"Statins":[1],"are":[2,21],"effective":[3],"in":[4,171,179,187,198,204],"preventing":[5],"cardiovascular":[6],"events,":[7],"but":[8],"patients":[9,20,128,155,170,197,255],"do":[10],"not":[11,235],"fully":[12],"adhere":[13,263],"to":[14,24,83,95,213,226,238,262],"them.":[15],"OBJECTIVE:":[16],"To":[17],"determine":[18],"whether":[19,35],"more":[22,260],"adherent":[23],"generic":[25,77,142,173,200,257],"statins":[26,29,258],"versus":[27,202],"brand-name":[28,79,149,181,206,253],"(lovastatin,":[30],"pravastatin,":[31],"or":[32,63,78,109,244],"simvastatin)":[33],"and":[34,54,71,98,111,117,144,159,175,264],"greater":[36],"adherence":[37],"improves":[38],"health":[39],"outcomes.":[40],"DESIGN:":[41],"Observational,":[42],"propensity":[43],"score-matched,":[44],"new-user":[45],"cohort":[46],"study.":[47],"SETTING:":[48],"Linked":[49],"electronic":[50],"data":[51],"from":[52],"medical":[53],"pharmacy":[55],"claims.":[56],"PARTICIPANTS:":[57],"Medicare":[58],"beneficiaries":[59],"aged":[60],"65":[61],"years":[62],"older":[64],"with":[65,241,250],"prescription":[66],"drug":[67,245],"coverage":[68],"between":[69],"2006":[70],"2008.":[72],"INTERVENTION:":[73],"Initiation":[74],"of":[75,90,126,154,190,269],"a":[76,99,131,141,148,266,270],"statin.":[80],"MEASUREMENTS:":[81],"Adherence":[82],"statin":[84,132],"therapy":[85],"(measured":[86],"as":[87],"the":[88,134,172,180,188,191,199,205],"proportion":[89],"days":[91],"covered":[92],"[PDC]":[93],"up":[94],"1":[96],"year)":[97],"composite":[100,271],"outcome":[101,193],"comprising":[102],"hospitalization":[103],"for":[104,169,177],"an":[105],"acute":[106],"coronary":[107],"syndrome":[108],"stroke":[110],"all-cause":[112],"mortality.":[113],"Hazard":[114],"ratios":[115],"(HRs)":[116],"absolute":[118,216],"rate":[119,189,268],"differences":[120],"were":[121,162,259],"estimated.":[122],"RESULTS:":[123],"A":[124],"total":[125],"90,111":[127],"who":[129],"initiated":[130,140,147],"during":[133],"study":[135],"was":[136,156,167,194,218],"identified;":[137],"83,731":[138],"(93%)":[139],"drug,":[143],"6380":[145],"(7%)":[146],"drug.":[150],"The":[151,164,215],"mean":[152],"age":[153],"75.6":[157],"years,":[158],"most":[160],"(61%)":[161],"female.":[163],"average":[165],"PDC":[166],"77%":[168],"group":[174,182,201,207],"71%":[176],"those":[178,203,251],"(P<0.001).":[183],"An":[184],"8%":[185],"reduction":[186],"clinical":[192,272],"observed":[195],"among":[196],"(HR,":[208],"0.92":[209],"[95%":[210],"CI,":[211],"0.86":[212],"0.99]).":[214],"difference":[217],"-1.53":[219],"events":[220,228],"per":[221,229],"100":[222,230],"person-years":[223],"(CI,":[224],"-2.69":[225],"-0.19":[227],"person-years).":[231],"LIMITATION:":[232],"Results":[233],"may":[234],"be":[236],"generalizable":[237],"other":[239],"populations":[240],"different":[242],"incomes":[243],"benefit":[246],"structures.":[247],"CONCLUSION:":[248],"Compared":[249],"initiating":[252,256],"statins,":[254],"likely":[261],"had":[265],"lower":[267],"outcome.":[273],"PRIMARY":[274],"FUNDING":[275],"SOURCE:":[276],"Teva":[277],"Pharmaceuticals.":[278]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":23},{"year":2017,"cited_by_count":20},{"year":2016,"cited_by_count":29},{"year":2015,"cited_by_count":14},{"year":2014,"cited_by_count":3},{"year":2012,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}